Company Overview and News

5
Sensex jumps 267 points tracking global cues, strong earnings

3h freepressjournal.in
Mumbai: The equity benchmark Sensex rallied for the fourth straight session Wednesday, and jumped 267 points, on encouraging second quarter earnings by tech major Infosys and positive global cues. The 30- share Sensex soared 267.26 points, or 0.76 per cent, to 35,429.74. It had rallied 1,161 points in the previous three sessions.
BAJAJ-AUTO 500325 RELIANCE 532977 BHRQY 533278 532215 532187 AXISBANK RIGD HDFCBANK 500570 BHARTIARTL TATAMOTORS CLNDY RLNIY YESBANK AXB INDUSINDBK IBN 532648 YYBKY VEDL AXBKY 532454 AXBA ICICIBANK HDB 532174 500180 COALINDIA TTM

5
Sensex logs first fall in 4 days, tanks 383 pts on rupee woes

3h freepressjournal.in
Mumbai: The BSE benchmark Sensex snapped its three-day gains, plunging 383 points due to heavy selling mainly in financial and auto stocks as rising crude prices and rupee volatility spooked investors. The flagship index swung nearly 880 points both ways on alternate bouts of buying and selling during the session. The NSE Nifty too fell by 131.70 points to slip below 10,500-mark. Intense selling pressure was witnessed in select counters led by auto, realty and oil&gas stocks.
BAJAJ-AUTO 500325 RELIANCE 532977 BHRQY 533278 532215 535789 500470 532187 AXISBANK RIGD HDFCBANK HEROMOTOCO 500570 BHARTIARTL TATAMOTORS CLNDY RLNIY YESBANK AXB INDUSINDBK 511072 IBN IDKQY 535322 532648 YYBKY VEDL REPCOHOME AXBKY 500182 IBULHSGFIN 532454 AXBA DHFL ICICIBANK TTST TATASTEEL TATLY HDB 532174 500180 HRTQY COALINDIA TTM

 
ICICI Bank files fraud case against Shrenuj promoter

3h livemint
New Delhi/Mumbai: ICICI Bank Ltd has moved a US court against 11 executives of Mumbai-based diamond company Shrenuj and Co. for allegedly defrauding the bank, and has sought to recover over $12 million (around ₹88.50 crore) from them, besides interest and legal fees.
ICICIBANK 532174 IBN

 
ICICI Bank offers full finance for car loans up to Rs 20 lakh in 4 hours

3h livemint
New Delhi: ICICI Bank is offering pre-approved car loans during the ongoing festive season up to 100% of the on-road price of the car, subject to a maximum of Rs 20 lakh in just four hours.
ICICIBANK 532174 IBN

5
Forbes list: This Indian company is among world’s 25 best employers; find out who leads rankings

3h financialexpress
Forbes’ global 2000 best employers list: Larsen & Toubro, a leading player in country’s engineering and construction sector, has featured at 22nd rank among the top 25 companies in the Forbes’ global 2000 best employers list. The chart is topped by Google parent Alphabet. Other than L&T, the only other Indian firms to feature in the top 100 list are Mahindra & Mahindra at 55, Grasim Industries at 59 and HDFC at 91.
GRASIM BAJAJ-AUTO PWQFY IOB 500820 500228 TCHQY 532977 532755 ASIANPAINT 532810 532215 532388 AXISBANK HDFCBANK HEROMOTOCO 500570 TATAMOTORS SBAZ GRSJY AXB KMBKY IBN JSWSTEEL TECHM AXBKY 500182 PFC GRSXY AXBA ICICIBANK HDB 532174 500180 KOTAKBANK 500300 HRTQY 500247 TTM

16
The Best Way For A Foreigner To Invest In India

2018-10-16 seekingalpha - 1
Do any of the existing ADRs offer an appropriate way to invest in the growth of the Indian domestic economy?
MMYT IBN WNS INFY WIT ICICIBANK SIFY HDB 532174 500180 INFY HDFCBANK 500570 YTRA TATAMOTORS TTM

 
NCLT reserves order on liquidation of Unity Infra

2018-10-16 thehindubusinessline
The Mumbai bench of the National Company Law Tribunal (NCLT) has reserved its decision in the insolvency case of construction company Unity Infraprojects Ltd.
ICICIBANK 532174 IBN 532505 532746 UNITY UCOBANK SBAZ

 
RBI approves 3-year term for Sandeep Bakhshi as ICICI Bank chief

2018-10-16 freepressjournal.in
New Delhi: Adopting a seemingly cautious approach, the Reserve Bank has approved appointment of Sandeep Bakhshi as ICICI Bank’s Managing Director and Chief Executive Officer for three years as against a five-year term sought by the lender. ICICI Bank Tuesday informed the stock exchanges that the Reserve Bank of India (RBI) has cleared Bakhshi’s appointment for three years effective from October 15.
AXBKY YESBANK AXBA ICICIBANK AXB AXISBANK 532174 IBN 532648 YYBKY 532215

 
RBI approves 3-year term for Bakhshi as ICICI Bank chief

2018-10-16 thehindubusinessline
Adopting a seemingly cautious approach, the Reserve Bank has approved appointment of Sandeep Bakhshi as ICICI Bank’s Managing Director and Chief Executive Officer for three years as against a five-year term sought by the lender.
AXBKY YESBANK AXBA ICICIBANK AXB AXISBANK 532174 IBN 532648 YYBKY 532215

 
ICICI Bank Limited - Allotment of ESOP/ESPS

2018-10-16 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
ICICIBANK 532174 IBN

1
An evening walk down Dalal Street | Sensex jumps 297 pts amid stable rupee and oil prices

2018-10-16 moneycontrol
Bulls kept the momentum going on Dalal Street for third consecutive session on Tuesday as the Sensex gained nearly 300 points and all sectoral indices ended in the green despite mixed global cues. Stable rupee and crude oil prices, and healthy start to September quarter earnings season aided the rally.
BHRYY 500325 500469 500228 RELIANCE TCHQY FEDA 532218 532755 532215 535789 505200 SOUTHBANK 532187 AXISBANK 534816 RIGD FEDS HDFCBANK INFRATEL FEDERALBNK EICHERMOT RLNIY ECQRY AXB INDUSINDBK IBN IDKQY FDBAY JSWSTEEL TECHM AXBKY IBULHSGFIN AXBA ICICIBANK HDB 532174 500180

 
IBN / ICICI Bank Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-10-16 sec.gov
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
IBN

1
IIM Kozhikode Placement 2018: Student bags whopping Rs 38.5 lakh salary, average package at Rs 17.8 lakh

2018-10-16 financialexpress
IIM Kozhikode Placement 2018: The Indian Institute of Management, Kozhikode recently concluded its final placement for the 2016-18 session. A total of 382 students participated in the placement process in which the male to female ratio was 73:27. Top companies like Amazon, Microsoft, Airtel, HDFC Bank, Mahindra & Mahindra, Reliance Industries were among the 178 recruiters that participated in this year’s placement process.
500325 AXB IBN RELIANCE 532215 AXBKY AXBA ICICIBANK SGO HDB AXISBANK 532174 500180 RIGD HDFCBANK RLNIY

 
NIIF’s Fund of Funds invests Rs 660 cr in H-CARE 2

2018-10-16 thehindubusinessline
NIIF’s Fund of Funds has invested Rs 660 crore in HDFC’s real estate investment platform HDFC Capital Affordable Real Estate – 2 (H-CARE 2). The investment is done along with a wholly-owned subsidiary of one of NIIF’s shareholders - the Abu Dhabi Investment Authority (ADIA). This is the second investment from National Investment and Infrastructure Fund since its inception.
AXBKY SOUTHBANK AXBA ICICIBANK AXB AXISBANK 532174 IBN 532218 532215

 
Sandeep Bakshi’s appointment as ICICI Bank MD, CEO get RBI nod after Chanda Kochhar’s exit

2018-10-16 financialexpress
Private sector lender ICICI Bank Tuesday said the RBI has approved Sandeep Bakshi’s appointment as Managing Director and CEO of the bank for three years. After resignation of Chanda Kochhar, who was facing inquiry, earlier this month, the bank’s board had elevated Chief Operating Officer (COO) Bakshi as the new managing director and CEO for five years until October 3, 2023, subject to regulatory and other approvals.
ICICIBANK 532174 IBN

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to IBN / ICICI Bank Ltd. on message board site Silicon Investor.

ICICI Bank Ltd - (Nyse: IBN) ICICI Bank Ltd - (Nyse: IBN) ICICI Bank Ltd - (Nyse: IBN) Sibneft, perhaps a new Lukoil Sibneft, perhaps a new Lukoil Sibneft, perhaps a new Lukoil
IBNT - IB Net, Ltd. IBNT - IB Net, Ltd. IBNT - IB Net, Ltd. HIBNY: Hibernia Foods plc HIBNY: Hibernia Foods plc HIBNY: Hibernia Foods plc
vsrc formally ibnl vsrc formally ibnl vsrc formally ibnl
CUSIP: 45104G104